论文信息 - FDA Approval Summary: Osimertinib for Adjuvant Treatment of Surgically Resected Non–Small Cell Lung Cancer, a Collaborative Project Orbis Review - 字舞流文

FDA Approval Summary: Osimertinib for Adjuvant Treatment of Surgically Resected Non–Small Cell Lung Cancer, a Collaborative Project Orbis Review

Jiang Liu | R. Pazdur | U. Rohr | J. Beaver | H. Singh | N. Drezner | P. Mishra-Kalyani | Huiming Xia | Yangbing Li | Qiuyi Choo | Y. Shen | Paz J Vellanki | Abigail L Koch | Xiaoxue Li | J. F. Zirkelbach | Elitza Palazov | Aleksandr Gamarian | Arūnas Girčys | Nataliya Fesenko | Dianne Spillman | P. Vellanki | A. Girčys